文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Phenotypic heterogeneity defines B cell responses to repeated SARS-CoV-2 exposures through vaccination and infection.

作者信息

Kardava Lela, Lim James, Buckner Clarisa M, Lopes de Assis Felipe, Zhang Xiaozhen, Wang Wei, Melnyk Mattie L, El Merhebi Omar, Trihemasava Krittin, Teng I-Ting, Carroll Robin, Jethmalani Yogita, Castro Mike, Lin Bob C, Praiss Lauren H, Seamon Catherine A, Kwong Peter D, Koup Richard A, Serebryannyy Leonid, Nickle David C, Chun Tae-Wook, Moir Susan

机构信息

Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD 20892, USA.

Monoceros Biosystems, San Diego, CA 29130, USA.

出版信息

Cell Rep. 2025 Apr 22;44(4):115557. doi: 10.1016/j.celrep.2025.115557. Epub 2025 Apr 12.


DOI:10.1016/j.celrep.2025.115557
PMID:40222009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12080740/
Abstract

Long-lived humoral memory is key to durable immunity against pathogens yet remains challenging to define due to heterogeneity among antigen-reactive B cells. We addressed this gap through longitudinal sampling over the course of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccinations with or without breakthrough infection. High-dimensional phenotypic profiling performed on ∼72 million B cells showed that receptor-binding domain (RBD) reactivity was associated with five distinct immunoglobulin G (IgG) B cell populations. Two expressed the activation marker CD71, both correlated with neutralizing antibodies, yet the one lacking the memory marker CD27 was induced by vaccination and blunted by infection. Two were resting memory populations; one lacking CD73 arose early and contributed to cross-reactivity; the other, expressing CD73, arose later and correlated with neutralizing antibodies. The fifth, a rare germinal center-like population, contributed to recall responses and was highly cross reactive. Overall, robust and distinct responses to booster vaccination overcame the superiority of hybrid immunity provided by breakthrough infection.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d5/12080740/85ce09c429f1/nihms-2076671-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d5/12080740/35ceff4aef01/nihms-2076671-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d5/12080740/3d2bda238d62/nihms-2076671-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d5/12080740/169d47e98fc3/nihms-2076671-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d5/12080740/b0b466396d16/nihms-2076671-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d5/12080740/91890e8b0bf9/nihms-2076671-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d5/12080740/3715b01cbb2e/nihms-2076671-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d5/12080740/85ce09c429f1/nihms-2076671-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d5/12080740/35ceff4aef01/nihms-2076671-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d5/12080740/3d2bda238d62/nihms-2076671-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d5/12080740/169d47e98fc3/nihms-2076671-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d5/12080740/b0b466396d16/nihms-2076671-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d5/12080740/91890e8b0bf9/nihms-2076671-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d5/12080740/3715b01cbb2e/nihms-2076671-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d5/12080740/85ce09c429f1/nihms-2076671-f0008.jpg

相似文献

[1]
Phenotypic heterogeneity defines B cell responses to repeated SARS-CoV-2 exposures through vaccination and infection.

Cell Rep. 2025-4-22

[2]
Diversified humoral immunity and impacts of booster vaccines: SARS-CoV-2 antibody profile and Omicron BA.2 neutralization before and after first or second boosters.

Microbiol Spectr. 2024-10-3

[3]
Non-cross-reactive epitopes dominate the humoral immune response to COVID-19 vaccination - kinetics of plasma antibodies, plasmablasts and memory B cells.

Front Immunol. 2024

[4]
Role of SARS-CoV-2-specific memory B cells promoting immune protection after booster vaccination in solid organ transplantation.

Front Immunol. 2024

[5]
Effective cellular and neutralizing immunity against SARS-CoV-2 after mRNA booster vaccination is associated with pDC and B cell activation.

Front Immunol. 2025-5-12

[6]
Elucidating the Immune Response to SARS-CoV-2: Natural Infection versus Covaxin/Covishield Vaccination in a South Indian Population.

Viruses. 2024-7-23

[7]
mRNA vaccine-induced SARS-CoV-2 spike-specific IFN-γ and IL-2 T-cell responses are predictive of serological neutralization and are transiently enhanced by pre-existing cross-reactive immunity.

J Virol. 2025-3-18

[8]
Unravelling humoral immunity in SARS-CoV-2: Insights from infection and vaccination.

Hum Antibodies. 2024

[9]
Booster COVID-19 mRNA vaccination ameliorates impaired B-cell but not T-cell responses in older adults.

Front Immunol. 2024-12-9

[10]
Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response.

J Virol. 2022-8-10

本文引用的文献

[1]
Maintenance and functional regulation of immune memory to COVID-19 vaccines in tissues.

Immunity. 2024-12-10

[2]
Homologous but not heterologous COVID-19 vaccine booster elicits IgG4+ B-cells and enhanced Omicron subvariant binding.

NPJ Vaccines. 2024-7-17

[3]
A guide to adaptive immune memory.

Nat Rev Immunol. 2024-11

[4]
SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial.

Lancet Microbe. 2024-6

[5]
Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccines.

Nature. 2024-6

[6]
Correlates of protection against symptomatic SARS-CoV-2 in vaccinated children.

Nat Med. 2024-5

[7]
Immunological imprinting shapes the specificity of human antibody responses against SARS-CoV-2 variants.

Immunity. 2024-4-9

[8]
SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase.

Immunity. 2024-3-12

[9]
Appearance of tolerance-induction and non-inflammatory SARS-CoV-2 spike-specific IgG4 antibodies after COVID-19 booster vaccinations.

Front Immunol. 2023

[10]
Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting.

Nature. 2024-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索